These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31162269)

  • 21. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.
    Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ
    J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal Hemorrhage.
    Alongi P; Vetrano IG; Fiasconaro E; Alaimo V; Laudicella R; Bellavia M; Rubino F; Bagnato S; Galardi G
    Curr Radiopharm; 2019; 12(1):88-92. PubMed ID: 30117406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraindividual Comparison of
    Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
    J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain.
    Sadeq A; Usmani S; Esmail AA; Fathallah W; Alfeeli MA; Marafi F
    Clin Nucl Med; 2022 Jul; 47(7):627-628. PubMed ID: 35675136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of 18F-Prostate-Specific Membrane Antigen 1007 in Imaging of Tumor Thrombus of Renal Cell Carcinoma.
    Zeng Y; Luo J; Liao H; Chen P
    Clin Nucl Med; 2021 Aug; 46(8):697-699. PubMed ID: 33883493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudoprogression on 68Ga-Prostate-Specific Membrane Antigen-11 PET/CT in a Treated Glioblastoma.
    Gupta M; Choudhury PS; Gairola M; Premsagar IC; Rao SA
    Clin Nucl Med; 2020 Aug; 45(8):621-622. PubMed ID: 32520501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-Prostate-Specific Membrane Antigen 1007 and 18F-FCH PET/CT in Local Recurrence of Prostate Cancer.
    Witkowska-Patena E; Giżewska A; Miśko J; Dziuk M
    Clin Nucl Med; 2019 Jun; 44(6):e401-e403. PubMed ID: 30932984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 177Lu-/68Ga-PSMA Theranostics in Recurrent Glioblastoma Multiforme: Proof of Concept.
    Kumar A; Ballal S; Yadav MP; ArunRaj ST; Haresh KP; Gupta S; Damle NA; Garg A; Tripathi M; Bal C
    Clin Nucl Med; 2020 Dec; 45(12):e512-e513. PubMed ID: 32558721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[
    Harat M; Małkowski B; Roszkowski K
    Radiat Oncol; 2019 Mar; 14(1):37. PubMed ID: 30832691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorine-18 Prostate-specific Membrane Antigen-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Diagnostics of Local Recurrence in a Prostate Cancer Patient After Recent Radical Prostatectomy.
    Paddubny K; Freitag MT; Kratochwil C; Koerber S; Radtke JP; Sakovich R; Kopka K; Giesel FL
    Clin Genitourin Cancer; 2018 Apr; 16(2):103-105. PubMed ID: 29111176
    [No Abstract]   [Full Text] [Related]  

  • 31. Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT.
    Witkowska-Patena E; Budzyńska A; Giżewska A; Dziuk M; Walęcka-Mazur A
    Ann Nucl Med; 2020 Mar; 34(3):192-199. PubMed ID: 31902120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicentric glioma studied with positron emission tomography: a case report.
    Sato K; Kameyama M; Ishiwata K; Kayama T; Yoshimoto T; Ito M
    Surg Neurol; 1994 Jul; 42(1):14-8. PubMed ID: 7940089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas.
    Bertagna F; Albano D; Cerudelli E; Gazzilli M; Giubbini R; Treglia G
    Curr Radiopharm; 2020; 13(2):94-98. PubMed ID: 31625482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular imaging with 68Ga-PSMA PET/CT in high grade glioma: A biomarker for tumour neo-angiogenesis.
    Usmani S; Riyami KA; Numani SP; Hashmi SF; Jain A; Sukaiti RA; Ahmed N; Shamim MS
    J Pak Med Assoc; 2024 Aug; 74(8):1552-1554. PubMed ID: 39160736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemangioma of the Ilium Simulating Bone Metastasis on 18 F-PSMA-1007 PET/CT.
    Dong A; Nian S; Bai Y; Zuo C
    Clin Nucl Med; 2024 Jun; 49(6):e304-e306. PubMed ID: 38377381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
    Lam WW; Ng DC; Wong WY; Ong SC; Yu SW; See SJ
    Clin Neurol Neurosurg; 2011 Feb; 113(2):156-61. PubMed ID: 21036467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
    Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.
    Lundemann M; Munck Af Rosenschöld P; Muhic A; Larsen VA; Poulsen HS; Engelholm SA; Andersen FL; Kjær A; Larsson HBW; Law I; Hansen AE
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):603-613. PubMed ID: 30276440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of Dynamic O-(2-[
    Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
    World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
    Song PJ; Lu QY; Li MY; Li X; Shen F
    J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.